Reprogramming the pluripotent cell cycle: restoration of an abbreviated G1 phase in human induced pluripotent stem (iPS) cells.
about
The cell cycle as a brake for β-cell regeneration from embryonic stem cellsUsing biomaterials to study stem cell mechanotransduction, growth and differentiationEffects of Cell Cycle Regulators on the Cell Cycle Synchronization of Porcine induced Pluripotent Stem Cells.Frequent co-expression of miRNA-5p and -3p species and cross-targeting in induced pluripotent stem cells.CstF-64 supports pluripotency and regulates cell cycle progression in embryonic stem cells through histone 3' end processing.Computational analysis of expression of human embryonic stem cell-associated signatures in tumors.Age-related impairment of bones' adaptive response to loading in mice is associated with sex-related deficiencies in osteoblasts but no change in osteocytes.cAMP and EPAC Signaling Functionally Replace OCT4 During Induced Pluripotent Stem Cell Reprogramming.Epigenetic control of cell cycle-dependent histone gene expression is a principal component of the abbreviated pluripotent cell cycle.The expression pattern of PFKFB3 enzyme distinguishes between induced-pluripotent stem cells and cancer stem cells.A high-content platform to characterise human induced pluripotent stem cell linesDNA synthesis is required for reprogramming mediated by stem cell fusionEstrogen receptor α mediates proliferation of osteoblastic cells stimulated by estrogen and mechanical strain, but their acute down-regulation of the Wnt antagonist Sost is mediated by estrogen receptor β.miR-302 regulates pluripotency, teratoma formation and differentiation in stem cells via an AKT1/OCT4-dependent manner.The abbreviated pluripotent cell cycle.Human induced pluripotent cells resemble embryonic stem cells demonstrating enhanced levels of DNA repair and efficacy of nonhomologous end-joining.Mechanisms maintaining genomic integrity in embryonic stem cells and induced pluripotent stem cellsTargeted gene therapies: tools, applications, optimizationSystematic review of induced pluripotent stem cell technology as a potential clinical therapy for spinal cord injury.Genome damage in induced pluripotent stem cells: assessing the mechanisms and their consequences.Molecular mechanisms controlling the cell cycle in embryonic stem cells.Quality control: Genome maintenance in pluripotent stem cells.Crosstalk between stem cell and cell cycle machineries.Full biological characterization of human pluripotent stem cells will open the door to translational research.Highly coordinated proteome dynamics during reprogramming of somatic cells to pluripotency.Atypical heterochromatin organization and replication are rapidly acquired by somatic cells following fusion-mediated reprogramming by mouse ESCs.Stabilization of mouse haploid embryonic stem cells with combined kinase and signal modulationCell-cycle-dependent Ca2+ transients in human induced pluripotent stem cells revealed by a simultaneous imaging of cell nuclei and intracellular Ca2+ level.Repression of the Aryl Hydrocarbon Receptor Is Required to Maintain Mitotic Progression and Prevent Loss of Pluripotency of Embryonic Stem Cells.JMJD5 regulates cell cycle and pluripotency in human embryonic stem cells.Inheritance of OCT4 predetermines fate choice in human embryonic stem cells
P2860
Q28076123-70CD95E0-42AE-43A2-BED0-28606A8E98A2Q29030919-5785FA3C-BDD5-4E1C-9A74-3DEB91E92E21Q33615135-3BA3ECAC-6B2D-4350-88D8-47993FEBB777Q33754656-E506D27F-9D73-4F6B-903F-9FA2B70B0A48Q33983624-7E8E0457-3290-44AE-97F6-D49589BC4BD7Q34063075-78C00DC4-F8E5-4FE2-96F2-DE5B5E6075B0Q34643886-2156CE1E-94CA-497B-AB25-C17A5BA22429Q35594855-D3340019-4E59-4A6D-91C9-6AB5DF316270Q36277309-47BC5C63-4564-41C6-952C-F65C2DCCD9CCQ36557422-B379E8D4-F865-479F-8734-3E6E07D8C469Q36637076-AB4DE473-4B64-4B91-BA75-E3C5DCBE652DQ36708307-485BA4EA-150E-4620-907F-6A52B96A4CDDQ36724963-3E32E3E9-9471-4B2E-A152-0168ABE41B9DQ36751720-CA65D8D1-2127-45B2-8B43-D220DF81DD8EQ36886887-AF0D89E6-2231-4B14-9091-85C2563F7722Q37414043-337BE398-0975-41E7-98B8-4CE639D3C9D2Q37902368-34E34E08-2F5B-493A-9780-C064A2B908D1Q38005211-BECEBC57-B36A-4639-A9FF-C54E7CE64E3BQ38040207-EFC1A10F-6A4A-4730-9384-83BB984E40D8Q38061614-04FEDDD2-79BB-4167-91A7-05565B02168DQ38129768-20BCF314-5022-410C-9510-0B5028B63A65Q38180443-55094D47-D446-418F-A509-276A5287A15DQ38621243-65BFBCD3-0E8E-4B3A-98F8-D7DEBC646ECBQ38871443-1DD55004-D6E9-4E16-AF3E-1EACCBEF40CFQ39222337-05872E07-49B9-4FD2-BEC5-85AB49D745CAQ41860383-15D0C197-9FA6-4306-96CA-11337FBA202FQ42379004-09C7CB2B-8171-45F9-895A-7505EBF8CCF0Q51143196-2FFD5446-857B-4716-A051-B29138013506Q51665673-163951A5-4DC8-474D-854B-1594638EDC29Q53057180-4D91AE5A-BE8B-4E8C-9478-9CA1D07DCC73Q58769511-B60C30B8-253E-4D19-B841-C97943B91AA1
P2860
Reprogramming the pluripotent cell cycle: restoration of an abbreviated G1 phase in human induced pluripotent stem (iPS) cells.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Reprogramming the pluripotent ...... pluripotent stem (iPS) cells.
@ast
Reprogramming the pluripotent ...... pluripotent stem (iPS) cells.
@en
Reprogramming the pluripotent ...... human induced pluripotent stem
@nl
type
label
Reprogramming the pluripotent ...... pluripotent stem (iPS) cells.
@ast
Reprogramming the pluripotent ...... pluripotent stem (iPS) cells.
@en
Reprogramming the pluripotent ...... human induced pluripotent stem
@nl
prefLabel
Reprogramming the pluripotent ...... pluripotent stem (iPS) cells.
@ast
Reprogramming the pluripotent ...... pluripotent stem (iPS) cells.
@en
Reprogramming the pluripotent ...... human induced pluripotent stem
@nl
P2093
P2860
P356
P1476
Reprogramming the pluripotent ...... pluripotent stem (iPS) cells.
@en
P2093
Andre J van Wijnen
Gary S Stein
Jane B Lian
Janet L Stein
Matthew Mandeville
Prachi N Ghule
Ricardo Medina
Zbigniew Dominski
P2860
P304
P356
10.1002/JCP.22440
P577
2011-05-01T00:00:00Z